Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02187510
Other study ID # CSPTNeonat2014_01
Secondary ID
Status Completed
Phase N/A
First received June 6, 2014
Last updated April 27, 2016
Start date July 2014
Est. completion date March 2016

Study information

Verified date April 2016
Source Corporacion Parc Tauli
Contact n/a
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the umbilical cord milking in preterm infants born by cesarian section less than 34 weeks is more effective than delayed cord clamping to obtain higher levels of hemoglobin.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Preterm infants less than 34 weeks' gestation born by cesarean section

Exclusion Criteria:

- Inability to obtain informed consent from the mother state

- Monochorionic-monoamniotic twin gestation

- Placenta abruption

- Uterine rupture

- Transplacental cesarean

- Hydrops fetalis

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Umbilical cord milking
Once the preterm is born keep the baby from the mother's thighs. The obstetrician cord milking three times (2seconds/milking) taking the cord from the base 20cm respect towards the baby. Then clamp de cord.
Delayed cord clamping
Once the preterm is born the neonatologist keep the baby beside the mother at level of the operating table during 30 seconds without cord clamping. The baby is covered with a polythene bag and put a cap on his head. Then the obstetritian clamp the cord.

Locations

Country Name City State
Spain Corporacio Sanitaria Parc Tauli Sabadell Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Corporacion Parc Tauli

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Haemoglobin g/dl 1 hour and 24 hours at born No
Secondary Apgar Score Basic score to mesure the newborn status. From 0 to 10. 1 and 5 minutes No
Secondary Arterial pressure Mean of systolic and dyastolic arterial pressure in mm Hg 2, 6, 12, 24, 36 and 48 hours of life No
Secondary Orine volume Total volume of orine at 24 and 48 hours of life. Total ml. 24 and 48 hours of life No
Secondary Use of vasopresors drugs To use or not to use the vasopresors drugs during the first 24 hours of life 24 hours of life No
Secondary Number of concentrate hematies transfusion Total number of concentrate hematies transfusions during the hospital stay. The stay should vary depending of the gestacional age, from 2 weeks up to 3 months. participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months) No
Secondary Intraventricular hemorrhage Presence of intraventricular hemorrhage mesured by cerebral ultrasound Degree of the hemorrhage by Papile participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months) No
Secondary Bronchopulmonary dysplasia Presence of Bronchopulmonary dysplasia and the degree, mesured by Spanish classification (M. Sanchez Luna) participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months) No
Secondary Total intensive care unit stay Mesured in days. The stay should vary depending of the gestacional age, from 2 weeks up to 3 months. Participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months) No
Secondary Hematocrit In percentage 1 hour and 24 hours at born No
See also
  Status Clinical Trial Phase
Terminated NCT02550054 - Erythropoietin in Premature Infants to Prevent Encephalopathy Phase 2
Completed NCT03827252 - Respiratory Stability and Vegetative Coupling During Neonatal Skin-to-skin Care
Active, not recruiting NCT03345069 - Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
Completed NCT04067206 - The Effects Of Auditory Interventions On Pain And Comfort In Premature Infants N/A
Completed NCT03911674 - Effects of Oral Stimulation in Preterm Infants Phase 3
Completed NCT03324126 - Individualized Fortification of Breast Milk N/A
Completed NCT03704012 - Efficacy of Massage Applied by the Parents in Hospitalized Premature Birth (PreMas) N/A
Active, not recruiting NCT03241082 - Ultrasound Assessment of BC in the NICU
Completed NCT03701906 - Effect of a Mixture of New Probiotic Strains in Preterm Infants N/A
Completed NCT02133716 - Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm Phase 4
Not yet recruiting NCT05543005 - Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants N/A
Recruiting NCT03852641 - Feeding Premature Infants During Non-invasive Respiratory Support N/A
Active, not recruiting NCT03423914 - Efficacy of Expressive Writing in Mothers of Preterm Infants N/A
Recruiting NCT04648787 - A Study of Family-integrated Care for Reducing Uncertainty N/A
Recruiting NCT04866342 - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor N/A
Not yet recruiting NCT02601872 - Erythropoietin in Premature Infants to Prevent Encephalopathy Phase 2
Not yet recruiting NCT02534090 - Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy N/A
Recruiting NCT06212427 - Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) N/A
Suspended NCT03939169 - The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP) N/A
Completed NCT03683316 - Work of Breathing and Kangaroo Mother Care